Medios AG (ETR:ILM1)

Market Cap	366.26M
Revenue (ttm)	1.97B
Net Income (ttm)	18.83M
Shares Out	25.51M
EPS (ttm)	0.74
PE Ratio	19.46
Forward PE	11.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,686
Average Volume	31,925
Open	14.50
Previous Close	14.36
Day's Range	14.38 - 14.64
52-Week Range	9.98 - 16.92
Beta	1.32
RSI	50.05
Earnings Date	Nov 11, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2016
• Employees: 952
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: ILM1

Financial Performance

In 2024, Medios AG's revenue was 1.88 billion, an increase of 5.51% compared to the previous year's 1.78 billion. Earnings were 12.55 million, a decrease of -33.29%.